Ann Arbor, MI, United States of America

EunGi Kim

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of EunGi Kim in Cancer Treatment

Introduction

EunGi Kim is a prominent inventor based in Ann Arbor, MI, known for his groundbreaking work in cancer treatment. With a portfolio of eight patents, he has made significant strides in developing novel therapeutic strategies targeting critical molecular pathways involved in various diseases, particularly cancers.

Latest Patents

Among his latest patents, EunGi Kim has developed small molecules known as ASH1L degraders, which include a first domain that binds to ASH1L and a second domain designed to facilitate its degradation. These ASH1L-targeting proteolysis targeting chimeras (PROTACs) advance methods for the treatment of diseases such as acute leukemia and solid tumors, demonstrating promising potential for overcoming resistance mechanisms in cancer therapy.

In addition to ASH1L degraders, he has also worked on GAS41 inhibitors. His research has culminated in small molecules that effectively bind to GAS41 and inhibit its activity, paving the way for new methods of cancer treatment.

Career Highlights

EunGi Kim has been associated with the University of Michigan, where he has contributed to leading-edge research in molecular biology and pharmacology. His expertise and innovative approaches have positioned him as a key figure in the field, allowing him to stay at the forefront of oncological advancements through his inventions.

Collaborations

Throughout his career, EunGi Kim has collaborated with esteemed colleagues, including Jolanta Grembecka and Tomasz Cierpicki. These collaborations have enriched his research endeavors and facilitated the development of effective therapeutic strategies in treating complex diseases.

Conclusion

EunGi Kim's contributions to the field of cancer research underscore his status as a notable inventor. His patents, which focus on ASH1L and GAS41, reveal a commitment to innovating cancer treatment solutions. As he continues his work, his advancements will likely have a profound impact on the future of medicine and oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…